Priya S. Chockalingam
Vice President, Head of Clinical Bioanalytics & Translational Sciences Beam Therapeutics
Seminars
Friday 31st October 2025
Identifying the Role of Clinical Biomarkers in Genome Editing Therapeutics for Sickle Cell Disease
3:30 pm
• Biomarkers to support efficacy of gene editing therapies to treat sickle cell disease
• Specialized biomarker discovery to assess disease pathophysiology
• Importance and opportunity biomarkers bring to accelerate clinical development
